Skip to Content

EP 107 (Acetazolamide extended release 500 mg)

Pill imprint EP 107 has been identified as Acetazolamide extended release 500 mg.

Acetazolamide is used in the treatment of mountain sickness / altitude sickness; pseudotumor cerebri; edema; hydrocephalus; glaucoma (and more), and belongs to the drug classes carbonic anhydrase inhibitor anticonvulsants, carbonic anhydrase inhibitors. Risk cannot be ruled out during pregnancy. Acetazolamide 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Acetazolamide extended release 500 mg EP 107
Acetazolamide extended release 500 mg EP 107
Discount Card Promo
Acetazolamide extended release
EP 107
500 mg
Orange & White
25.00 mm
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Carbonic anhydrase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Zydus Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
ammonio methacrylate copolymer type A
ammonio methacrylate copolymer type B
FD&C Yellow No. 6
microcrystalline cellulose
sodium lauryl sulfate
magnesium silicate
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0401 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.